Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Americans’ becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey

by
August 2, 2025
in Health Care
0
Americans’ becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows.

The YouGov poll, released Friday, shows that at least 80 percent of respondents have heard at least “a little bit” about semaglutide, a medication used to treat Type 2 diabetes that also helps a user to shed weight.

In March 2023, only 60 percent of Americans were aware of the drug. A year later, in March 2024, that number had jumped to 70 percent, the pollster noted. The latest survey also shows that the share of those who have heard “a lot” about the medication has nearly doubled since 2023, increasing to 41 percent from 23 percent.

Just 36 percent of respondents say they know someone who has taken semaglutide. Around 14 percent listed a family member took the medicine, 16 percent named a friend, 11 percent identified an acquaintance and 7 percent said they had taken it themselves, according to the poll. Several also noted they knew a user in more than one category.

Women are more likely than men, 43 percent to 29 percent, to know someone — including themselves — who has taken a GLP-1 agonist drug, per the survey.

The weight loss medications — including Wegovy, Ozempic, Zepbound and others — have been available since 2005 but have only in the past few years been used to treat obesity. The drugs work by mimicking a hormone in the body — glucagon-like peptide-1 — that stimulates insulin secretion and reduces appetite.

Possible side effects of taking the medication include nausea, diarrhea, vomiting, and constipation.

While semaglutide is currently only prescribed for weight loss or treating diabetes, early research is pointing to possible benefits for a host of other issues, including treatment for addiction, neurodegenerative diseases and conditions that affect the heart, kidney or liver.

The latest survey found that roughly a quarter of respondents said they would be “very” or “somewhat” interested in taking the medication as a weight loss treatment.

About a third of Americans have either taken the drug or said they would be interested in trying it. On the other side, about 17 percent said they were “not very” interested in the medication and 45 percent signaled they were not at all interested.

A separate poll from last September found that around a quarter of adults in the U.S. would consider using weight loss medications without consulting their doctor.

The YouGov analysis is based on an online survey conducted from May 22-25 among 1,109 adults in the U.S. The margin of error for the full sample is 4 percentage points.

Previous Post

Flu, COVID can reawaken dormant breast cancer cells: Study

Next Post

Kennedy targets vaccination injury program

Next Post
Kennedy targets vaccination injury program

Kennedy targets vaccination injury program

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    HHS de-recognizing unions representing staffers at CDC, FDA, NIH and more

    HHS de-recognizing unions representing staffers at CDC, FDA, NIH and more

    August 22, 2025
    US oil and gas air pollution is causing unequal health impacts: Study

    US oil and gas air pollution is causing unequal health impacts: Study

    August 22, 2025
    Planned Parenthood sues South Carolina over Medicaid ban

    Planned Parenthood sues South Carolina over Medicaid ban

    August 22, 2025

    Trending

    About one in three U.S. women are accessing family planning services: CDC

    About one in three U.S. women are accessing family planning services: CDC

    December 11, 2024
    Some measles patients in West Texas show signs of vitamin A toxicity, doctors say, raising concerns about misinformation

    Some measles patients in West Texas show signs of vitamin A toxicity, doctors say, raising concerns about misinformation

    March 28, 2025
    Battle over Biden’s future drowns out abortion drumbeat

    Battle over Biden’s future drowns out abortion drumbeat

    July 14, 2024
    RFK Jr. says Trump ‘assured’ him of role in White House

    RFK Jr. says Trump ‘assured’ him of role in White House

    November 4, 2024

    Recent News

    HHS de-recognizing unions representing staffers at CDC, FDA, NIH and more

    HHS de-recognizing unions representing staffers at CDC, FDA, NIH and more

    August 22, 2025
    US oil and gas air pollution is causing unequal health impacts: Study

    US oil and gas air pollution is causing unequal health impacts: Study

    August 22, 2025

    Popular News

    • HHS de-recognizing unions representing staffers at CDC, FDA, NIH and more
    • US oil and gas air pollution is causing unequal health impacts: Study

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.